Study guide
19.3 Nonpharmacologic Outcome Monitoring
ANCC Family Nurse Practitioner FNP-BC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Application, and Test Day 1.3 Blueprint Weights, TCO Dates, and Study Strategy
2 Assessment Foundations
2.1 Population Health Promotion and Screening 2.2 Comprehensive History and Physical 2.3 Focused History and Physical 2.4 Age-Specific Screening Schedules
3 Function, Risk, and Lifespan Assessment
3.1 Functional Assessment 3.2 Risk Assessment and Social Determinants 3.3 Pediatric Developmental Assessment 3.4 Adolescent, Adult, and Geriatric Assessment
4 Diagnosis Foundations
4.1 Pathogenesis and Pathophysiology 4.2 Diagnostic Test and Procedure Selection 4.3 Interpreting Labs and Imaging 4.4 Normal vs Abnormal Physiologic Change
5 Differential Diagnosis
5.1 Formulating Differential Diagnoses 5.2 Red Flags and Emergency Identification 5.3 Diagnostic Reasoning Traps
6 Prevention and Anticipatory Guidance
6.1 Primary, Secondary, and Tertiary Prevention 6.2 Pediatric and Adolescent Anticipatory Guidance 6.3 Adult and Geriatric Anticipatory Guidance 6.4 Immunization Planning Across the Lifespan
7 Guidelines, Culture, and Evidence
7.1 Crisis, Safety, and End-of-Life Planning 7.2 Clinical Guidelines and Standards of Care 7.3 Culturally and Ethnically Sensitive Practice 7.4 Evidence-Based Research Appraisal
8 Care Plans and Shared Decisions
8.1 Shared Decision-Making 8.2 Multimorbidity and Prioritization 8.3 Referral, Comanagement, and Transitions
9 Pharmacotherapeutics
9.1 Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics 9.2 Interactions, Contraindications, and Monitoring 9.3 Special-Population Prescribing 9.4 High-Alert Medications and Analgesic Safety
10 Cardiovascular Primary Care
10.1 Cardiovascular Diagnosis 10.2 Cardiovascular Pharmacotherapy 10.3 Nonpharmacologic Cardiovascular Management 10.4 Lifespan Cardiovascular Issues
11 Respiratory Primary Care
11.1 Respiratory Diagnosis 11.2 Respiratory Pharmacotherapy 11.3 Lifespan Respiratory Care
12 Endocrine and Metabolic Primary Care
12.1 Diabetes Diagnosis and Monitoring 12.2 Diabetes Pharmacotherapy 12.3 Thyroid and Other Endocrine Disorders 12.4 Obesity and Metabolic Disease
13 Gastrointestinal Primary Care
13.1 Gastrointestinal Diagnosis 13.2 GI Pharmacotherapy and Nutrition 13.3 Lifespan Gastrointestinal Care
14 GU, Renal, and Reproductive Primary Care
14.1 GU and Renal Diagnosis and Management 14.2 Women's Reproductive Health 14.3 Pregnancy and Postpartum Primary Care 14.4 Men's Health and Sexual Function
15 HEENT, Skin, and Musculoskeletal
15.1 HEENT Diagnosis and Management 15.2 Integumentary Diagnosis and Management 15.3 Musculoskeletal Diagnosis 15.4 MSK Procedures and Nonpharmacologic Care
16 Neuro, Psych, Heme, Immune, and Infection
16.1 Neurological Diagnosis and Management 16.2 Psychiatric Diagnosis and Substance Use 16.3 Hematopoietic and Immune Disorders 16.4 Common Infections and Anti-Infectives
17 Clinical Delivery Skills
17.1 Office Procedures and Nonpharmacologic Treatment 17.2 Patient-Specific Education 17.3 Therapeutic Communication 17.4 Comprehensive Documentation
18 Professional Practice
18.1 Legal and Ethical Implications 18.2 Health IT, EHR, and AI Ethics 18.3 Regulatory Guidelines: Reportable Disease and Abuse 18.4 APRN Scope, Standards, and FNP Role
19 Outcome Evaluation
19.1 Ethical and Legal Evaluation Issues 19.2 Pharmacotherapeutic Outcome Monitoring 19.3 Nonpharmacologic Outcome Monitoring 19.4 Clinical Data, PROs, and Treatment Efficacy
20 Follow-Up, Systems, and Exam Strategy
20.1 Follow-Up Intervals and Surveillance 20.2 Treatment Adjustment and Deprescribing 20.3 Resource Management and Care Coordination 20.4 Exam-Day Strategy and TCO Review
19.3 Nonpharmacologic Outcome Monitoring
Key Takeaways Explain This Topic AI
Physical therapy and other musculoskeletal plans are evaluated with function (WOMAC or KOOS conceptually, stairs, work), not a demand that pain reach zero.
CPAP outcome is download hours and residual AHI, not machine ownership; sparse use is nonimplementation until mask, leak, cost, and literacy barriers are fixed.
DASH and sodium reduction are judged on a home blood-pressure trend over weeks; CBT and motivational interviewing are judged on PHQ-9 or GAD-7 change, session dose, and function.
Wound and I&D outcomes are trajectory; biopsy and imaging outcomes are a result a named clinician saw and acted on.
“Conservative care failed” is false if PT, CPAP, diet, or CBT was never delivered because of access, cost, or health literacy.
Last updated: August 2026
Official Domain V knowledge includes non-pharmacologic intervention and treatment outcomes . Implementation (Chapter 17.1 and the system chapters) is the procedure, the splint, the CPAP order, the physical-therapy referral, and the DASH handout. Evaluation is whether those actions changed function , and whether they were ever actually done .
A pill bottle at least exists as an object. Nonpharmacologic plans die quietly: the PT authorization sat in a queue, the biopsy result sat in an in-basket, the CPAP machine is a coat rack, the DASH diet was a PDF the patient could not read. If you only ask “how is the pain,” you will score the intervention wrong.
Function is the outcome — pain is one input
For musculoskeletal care — mechanical low back pain, knee osteoarthritis, rotator-cuff tendinopathy — the evidence-based intervention is usually physical therapy, activity modification, weight reduction, and time , not an MRI on day 4. Evaluating that plan by a 0–10 pain number alone misses the point of PT.
Use a function score the patient can repeat:
Condition Outcome that counts What “success” looks like
Knee OA / after PT WOMAC or KOOS conceptually; sit-to-stand, stairs, walking distance Walks to the mailbox, sleeps, climbs a flight; pain may not be zero
Low back pain Oswestry or a simple “days of work missed,” sit-to-stand, walk time Return to work or school; neurologic red flags still absent
Shoulder Reach, dress, sleep on that side ADLs restored
Asthma nonpharm + controller ACT ; rescue-canister count; nights woken ACT ≥20 is the usual controlled cut; 16 is not a victory
BPH lifestyle / meds AUA-SI (IPSS) plus post-void residual when retention is in play Symptom-score drop and no silent retention
Depression / CBT or MI PHQ-9 change of about 5 points is a typical reliable change; <5 is remission language in many protocols Also ask function: work, relationships, sleep
Anxiety / CBT GAD-7 Same rule: number plus function
Obesity counseling Weight trend , waist, function, comorbidity (BP, A1c) About 5% weight loss is a clinically meaningful early outcome
Wound / ulcer Length × width × depth, undermining, granulation, odor, peri-wound Trajectory over days — not one photograph
I&D Fever gone, erythema receding, drainage controlled Day-2 worse and spreading is failure or missed deep space
CPAP for OSA Hours per night and residual AHI from the download “I have the machine” is not an outcome
A patient who says PT “didn’t work” but whose KOOS-function improved and who now works a full shift has a successful nonpharmacologic outcome and an unchanged pain identity. Treat the identity with education; do not declare PT a failure and rush to opioids or premature imaging. Conversely, a pain score of 2 with a new foot drop is a failed, dangerous course — function and neuro checks beat the smiley-face scale.
In a school-age athlete, days of school and practice missed are the PRO. In a frail adult, the outcome is transfers, toileting, and whether a caregiver can still manage at home — not a sports KOOS.
CPAP hours, not CPAP ownership
Obstructive sleep apnea treatment is evaluated with objective download data , not optimism. Adults generally need on the order of 4 or more hours per night on most nights for a fair trial of symptom and blood-pressure benefit; residual AHI should be in the controlled range. If the download shows 47 minutes on six nights in two months, the diagnosis is not “CPAP failed.” The diagnosis is the intervention was not implemented .
Evaluate why : mask leak, nasal obstruction, claustrophobia, cost of supplies, no electricity, partner objection, untreated insomnia, wrong pressure, no one taught the on-button. Fix the barrier (different interface, nasal steroid, humidification, desensitization, a dental referral if indicated, a social-work look at the electric bill) before you abandon PAP for a wakefulness drug. Document hours, leak, and residual AHI in the note — that is the outcome. A parent using the child’s unused CPAP “when they snore” is also not an evaluated treatment.
DASH, sodium, and the home-BP trend
Dietary Approaches to Stop Hypertension, sodium reduction (commonly toward <1,500–2,300 mg/day depending on the target you set with the patient), weight loss, alcohol limits, and aerobic activity are first-line hypertension therapy. You cannot evaluate them with a single clinic BP.
Use a home-BP log (validated cuff, seated, 5 minutes rest, two readings, morning and evening for several days) or ABPM when you need the truth. If the log never happened, the diet did not fail. Ask who shops, who cooks, whether the pantry is a food-bank box of canned soup, and whether the patient can read the label. A culturally familiar food pattern that cuts sodium and added sugar beats a pamphlet of New England recipes for a household that does not eat them.
Expect meaningful BP change from lifestyle over weeks , similar to the 2–4-week antihypertensive clock. Combine the diet outcome with the drug outcome; do not stop the ACE inhibitor because the patient “started DASH yesterday.” Do not call DASH a failure because the workplace cafeteria is fried chicken and the patient has no microwave — that is an implementation barrier (Section 19.1 justice, again).
CBT, MI, and the PHQ-9
Cognitive behavioral therapy, motivational interviewing, sleep restriction for insomnia, and peer support are treatments. Evaluate them like drugs: dose (sessions attended), clock (4–6 weeks for a fair CBT look in many protocols; MI may change a readiness ruler sooner), and instrument (PHQ-9, GAD-7, AUDIT-C).
A PHQ-9 that goes from 18 to 16 after one counseling sentence in clinic is not a CBT outcome. A PHQ-9 that goes from 18 to 7 over eight sessions, with return to work, is. If the score is unchanged and the patient never got an appointment because the only CBT clinician is 90 miles away and cash-pay, you have an access failure , not evidence that “talk therapy doesn’t work for her.” Offer a covered modality: integrated behavioral health, telehealth CBT, a community program, or a medication if that is the accessible evidence-based option — and say why.
Motivational interviewing is evaluated by a behavior change , not by how moving the conversation felt. Fewer heavy-drinking days, a completed colonoscopy, or a filled nicotine-replacement prescription is the outcome. A beautifully empathic visit that changes nothing still needs a different plan.
For an adolescent , include school function and a confidential suicide item, not only a parent’s report that “attitude is better.” For a perinatal patient, evaluate the Edinburgh score or PHQ-9 plus bonding and sleep, and do not wait six weeks if safety is in doubt.
Wound trajectory and procedure closed loops
Wounds should declare a direction. A clean surgical incision epithelializes; a venous ulcer should reduce area over 2–4 weeks with compression that was actually worn. Stalled or expanding wounds trigger a re-look: infection, ischemia (ABI), offloading failure, glucose, nutrition, retained foreign body. Photograph with a ruler; write measurements. “Looks better” is not an outcome.
Incision and drainage outcomes: systemic signs resolve, the cavity collapses, pain falls. Worse at 48 hours means loculations you missed, MRSA without indicated adjunctive antibiotics, the wrong diagnosis (necrotizing infection, hidradenitis you keep nicking, a hernia), or a deep-space problem you should not be managing in clinic.
Biopsy and imaging are nonpharmacologic interventions whose outcome is a result that someone saw and acted on . A punch biopsy of a pigmented lesion that sits unsigned in the in-basket for three weeks is a failed evaluation even if the dermatopathologist did perfect work. Close the loop: who received it, what the patient was told, whether excision margins or referral happened, and the next look. The same rule applies to a “routine” chest radiograph, an endometrial biopsy, or a Pap. A normal result that nobody filed is incomplete; an abnormal result that nobody called is harm.
Splint and fracture-care outcomes are function plus neurovascular status plus the follow-up radiograph you ordered, not “they left in a sling.” Suture outcomes are infection, dehiscence, and whether the patient returned for removal on the day you wrote down.
When nonpharm “failed” because it was never implemented
Build this into every evaluation visit:
Intended intervention Implementation check If it never happened
PT Authorization, first visit date, home-program adherence Navigate benefits; teach a real home program; community PT; do not jump to “failed conservative care” for surgery
CPAP Download hours and leak Barrier work, not abandonment
Diet 24-hour recall, sodium sources, food security Referral to an RD, medically tailored meals, food-pantry list
CBT / MI Session count Telehealth, integrated behavioral health, or a pharmacologic alternative with the reason documented
- Compression / offloading Was it worn? Can they don it? Different garment, caregiver teaching
- Pelvic-floor PT Attendance Same as PT
- Watchful waiting Did you actually recheck at the planned interval? A no-show is an incomplete evaluation
Cost, transportation, health literacy, language, caregiving burden, and distrust are the usual reasons. Naming them is not optional color. It is how you avoid blaming the patient for a system that never delivered the treatment you wrote down. An after-visit summary written at a graduate reading level is a literacy failure waiting to be scored as “nonadherence.”
Exam trap: “conservative therapy failed” after a 5-day home-exercise printout and no PT visit is not a surgical indication and is not an honest evaluation. Another trap: declaring CBT a failure because the patient declined a six-month waitlist, while you never offered telehealth or a medication. A third: calling a wound “stable” for four visits while the measurements quietly enlarge.
If you remember one nonpharmacologic-outcome sentence: measure function, download the device, close the biopsy loop, and do not fail a treatment that never arrived.
Loading diagram... Did the nonpharmacologic plan actually happen?